Skip to content

IBIO - iBio, Inc. - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchI

iBio, Inc. Common Stock

IBIO · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

I

IBIOiBio, Inc. Common Stock

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 21

52-wk high: $3.82
52-wk low: $0.74
Prev close: $2.19
Mkt cap: $74.0M
Beta: 1.31
P/S: 246.7x

Smart money

8 funds hold a position.

Real smart money

Funds holding this stock

8 holders

Combined position$13.4M

MI
Millennium
Israel Englander · Q2 2026 13F
$2.9M
position
CI
Citadel
Ken Griffin · Q2 2026 13F

Earnings

Earnings

Results versus expectations

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is running thin margins.

Net margin: 0.0%
Market cap: $74M

Valuation

P/S246.74
P/B0.93

Quality

Operating margin-9653.0%
ROE

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: IBIO
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Market cap: $74.02M
Beta: 1.31

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

P/B

0.9x

Profit margin

+0.0%

Op margin

-9653.0%

ROE

-62.1%

$2.4M

position

BA

Balyasny

Dmitry Balyasny · Q2 2026 13F

$2.0M

position

5 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 5 holders

Coverage gaps for IBIO

No recent insider trade
No recent Congress trade
No recent market-voice mention

No earnings history on record for this stock yet.

The next reported quarter will appear here

Next report

Reports Sep 4, 2026, in 14 days

EPS expected

-$0.08

-$0.09 to -$0.07

Revenue expected

$0.00

3 analysts

-62.1%

ROA-34.5%

Growth

Beta1.31